| A perspective on multi-target drugs for Alzheimer’s disease O Benek, J Korabecny, O Soukup Trends in pharmacological sciences 41 (7), 434-445, 2020 | 173 | 2020 |
| Synthesis and evaluation of frentizole-based indolyl thiourea analogues as MAO/ABAD inhibitors for Alzheimer’s disease treatment L Hroch, P Guest, O Benek, O Soukup, J Janockova, R Dolezal, K Kuca, ... Bioorganic & Medicinal Chemistry 25 (3), 1143-1152, 2017 | 59 | 2017 |
| A direct interaction between mitochondrial proteins and amyloid-β peptide and its significance for the progression and treatment of Alzheimer’s disease O Benek, L Aitken, L Hroch, K Kuca, F Gunn-Moore, K Musilek Current medicinal chemistry 22 (9), 1056-1085, 2015 | 48 | 2015 |
| A direct interaction between mitochondrial proteins and amyloid-β peptide and its significance for the progression and treatment of Alzheimer’s disease O Benek, L Aitken, L Hroch, K Kuca, F Gunn-Moore, K Musilek Current medicinal chemistry 22 (9), 1056-1085, 2015 | 48 | 2015 |
| Design, Synthesis and in vitro Evaluation of Indolotacrine Analogues as Multitarget‐Directed Ligands for the Treatment of Alzheimer's Disease O Benek, O Soukup, M Pasdiorova, L Hroch, V Sepsova, P Jost, ... ChemMedChem 11 (12), 1264-1269, 2016 | 42 | 2016 |
| Benzothiazoles-scaffold of interest for CNS targeted drugs L Hroch, L Aitken, O Benek, M Dolezal, K Kuca, F Gunn-Moore, K Musilek Current Medicinal Chemistry 22 (6), 730-747, 2015 | 40 | 2015 |
| Design, synthesis and in vitro evaluation of benzothiazole-based ureas as potential ABAD/17β-HSD10 modulators for Alzheimer’s disease treatment L Hroch, O Benek, P Guest, L Aitken, O Soukup, J Janockova, K Musil, ... Bioorganic & medicinal chemistry letters 26 (15), 3675-3678, 2016 | 39 | 2016 |
| 1-(Benzo[d]thiazol-2-yl)-3-phenylureas as dual inhibitors of casein kinase 1 and ABAD enzymes for treatment of neurodegenerative disorders O Benek, L Hroch, L Aitken, F Gunn-Moore, L Vinklarova, K Kuca, ... Journal of Enzyme Inhibition and Medicinal Chemistry 33 (1), 665-670, 2018 | 32 | 2018 |
| A systematic review on donepezil-based derivatives as potential cholinesterase inhibitors for Alzheimer’s disease J Korabecny, K Spilovska, E Mezeiova, O Benek, R Juza, D Kaping, ... Current Medicinal Chemistry 26 (30), 5625-5648, 2019 | 29 | 2019 |
| Novel benzothiazole-based ureas as 17β-HSD10 inhibitors, a potential alzheimer’s disease treatment L Aitken, O Benek, BE McKelvie, RE Hughes, L Hroch, M Schmidt, ... Molecules 24 (15), 2757, 2019 | 27 | 2019 |
| 6-Benzothiazolyl ureas, thioureas and guanidines are potent inhibitors of ABAD/17&: β-HSD10 and potential drugs for Alzheimer& O Benek, L Hroch, L Aitken, R Dolezal, P Guest, M Benkova, O Soukup, ... Medicinal Chemistry 13 (4), 345-358, 2017 | 27 | 2017 |
| 6-Benzothiazolyl ureas, thioureas and guanidines are potent inhibitors of ABAD/17&: β-HSD10 and potential drugs for Alzheimer& O Benek, L Hroch, L Aitken, R Dolezal, P Guest, M Benkova, O Soukup, ... Medicinal Chemistry 13 (4), 345-358, 2017 | 27 | 2017 |
| Discovery of novel berberine derivatives with balanced cholinesterase and prolyl oligopeptidase inhibition profile K Sobolova, M Hrabinova, V Hepnarova, T Kucera, T Kobrlova, ... European journal of medicinal chemistry 203, 112593, 2020 | 26 | 2020 |
| Friend or enemy? Review of 17β‐HSD10 and its role in human health or disease L Vinklarova, M Schmidt, O Benek, K Kuca, F Gunn‐Moore, K Musilek Journal of Neurochemistry 155 (3), 231-249, 2020 | 24 | 2020 |
| Novel caffeine derivatives with antiproliferative activity M Andrs, D Muthna, M Rezacova, M Seifrtova, P Siman, J Korabecny, ... RSC advances 6 (39), 32534-32539, 2016 | 21 | 2016 |
| Exploring the chemical space of benzothiazole-based DNA gyrase B inhibitors Z Skok, M Barančoková, O Benek, CD Cruz, P Tammela, T Tomašič, ... ACS medicinal chemistry letters 11 (12), 2433-2440, 2020 | 20 | 2020 |
| Benzothiazolyl ureas are low micromolar and uncompetitive inhibitors of 17β-HSD10 with implications to Alzheimer’s disease treatment M Schmidt, O Benek, L Vinklarova, M Hrabinova, L Zemanova, M Chribek, ... International Journal of Molecular Sciences 21 (6), 2059, 2020 | 18 | 2020 |
| Rational design of novel TLR4 ligands by in silico screening and their functional and structural characterization in vitro J Honegr, D Malinak, R Dolezal, O Soukup, M Benkova, L Hroch, O Benek, ... European Journal of Medicinal Chemistry 146, 38-46, 2018 | 18 | 2018 |
| Small‐molecule inhibitors of cyclophilin D as potential therapeutics in mitochondria‐related diseases A Haleckova, O Benek, L Zemanová, R Dolezal, K Musilek Medicinal Research Reviews 42 (5), 1822-1855, 2022 | 14 | 2022 |
| Tacrine and its derivatives in the therapy of Alzheimers disease J Korábečný, K Spilovská, O Benek, K Musílek, O Soukup, K Kuča Ceska a Slovenska Farmacie: Casopis Ceske Farmaceuticke Spolecnosti a …, 2012 | 12 | 2012 |
